Use of behavioral therapies for treatment of medical disorders, Part 1: Impact on management of patients with diabetes mellitus

In 2002, new Current Procedural Terminology (CPT) codes were established to allow providers to indicate when behavioral therapies were employed specifically for treatment of general medical disorders. In response, regional Centers for Medicare & Medicaid Services (CMS) carriers expressed interes...

Full description

Bibliographic Details
Main Author: Matchar, David B.
Corporate Authors: Duke University Evidence-based Practice Center, Technology Assessment Program (Agency for Healthcare Research and Quality), United States Agency for Healthcare Research and Quality
Format: eBook
Language:English
Published: Rockville, Maryland Agency for Healthcare Research and Quality 2004, Feburary 9, 2004
Series:Technology assessment report
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:In 2002, new Current Procedural Terminology (CPT) codes were established to allow providers to indicate when behavioral therapies were employed specifically for treatment of general medical disorders. In response, regional Centers for Medicare & Medicaid Services (CMS) carriers expressed interest in developing appropriate coverage decisions, accounting for available scientific evidence. CMS, through the Agency for Healthcare Research and Quality (AHRQ), requested the Duke Evidence-based Practice Center (EPC) to perform an evaluation of the evidence regarding a limited group of potential circumstances for the use of behavioral therapies for general medical disorders. The new health and behavior codes (Appendix A) concentrate on assessments and interventions aimed at improving physical health. The focus of the current analysis is thus on physical health status. Potential intervention targets cover a wide range of possibilities including patient adherence to general medical treatment, symptom expression, health-promoting behaviors, health-related risk-taking behaviors, and overall adjustment to general medical illness. In conjunction with the CMS regional carrier medical directors, three medical conditions were selected for systematic review, based on their clinical importance and their representativeness of the variety conditions for which behavioral therapies are commonly considered. This technology assessment focuses on the first condition selected: diabetes mellitus
Item Description:Title from PDF cover. - "White paper prepared for the Agency for Healthcare Research and Quality"--Page 2
Physical Description:1 PDF file (160 pages) illustrations